Sp500
AMERICAN GASTROENTEROLOGICAL ASSOCIATION CLINICAL PRACTICE GUIDELINE ON FECAL MICROBIOTA TRANSPLANTATION FOR GASTROINTESTINAL DISEASES
Date
May 19, 2024
Tracks
Related Products
FDA APPROVAL PAVES THE WAY FOR FUTURE MICROBIOME THERAPIES
This session highlights thecurrent FDA approved microbiome therapeutics and their applications and the exciting avenues being pursued for the next generation of microbiome therapeutics using gene editing and synthetic microbial communities…
Microbiome Therapeutics: Charting the Path to Clinical Success
SOCIETY: AGA The session will highlight the current state of microbiome therapeutics, the challenges with developing and testing them in humans and the outlook for future of microbiome therapies beyond FMT…